Literature DB >> 23024374

Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress.

Chao Tong1, Alex Morrison, Samantha Mattison, Su Qian, Mark Bryniarski, Bethany Rankin, Jun Wang, D Paul Thomas, Ji Li.   

Abstract

A "longevity " gene, sirtuin 1 (SIRT1), can attenuate age-dependent induction of left ventricular dysfunction. This study aimed to characterize the role of SIRT1 in the tolerance of aged heart to ischemic insults. Male C57BL/6 young (4-6 mo) and aged (24-26 mo) mice were used to determine the role of SIRT1 in myocardial ischemia/reperfusion (I/R) tolerance. SIRT1 localization was assessed by confocal microscopy. Immunoblotting was used to evaluate SIRT1 expression and translocation. The results demonstrated that SIRT1 is expressed predominantly as a sumoylated form in cardiomyocyte nuclei. Moreover, cardiac overexpression of desumoylase, sentrin-specific protease 2 (SENP2), significantly reduces nuclear sumoylated SIRT1 levels (P<0.05). Interestingly, I/R stress leads to desumoylation and translocation of nuclear SIRT1 into the cytoplasm in aged but not in young hearts. SIRT1 activity in ischemic young hearts was 3.2-fold higher than that seen in ischemic aged hearts, which suggests that aging causes impaired nucleocytoplasmic shuttling and activation of SIRT1 during ischemic stress. The infarct size in aged and Sirt1(+/-) knockout hearts was higher than that observed in young and Sirt1(+/+) WT littermate hearts, respectively (all P<0.05). SIRT1 agonist, SRT1720, reduced myocardial infarction in both aged and Sirt1(+/-) hearts. Therefore, impaired cardiac SIRT1 activity plays a critical role in the observed increase in susceptibility of the aged heart to I/R injury. SIRT1 agonist can restore this aging-related loss of cardioprotection.

Entities:  

Keywords:  Sirtuin 1; myocardial infarction; sumoylation

Mesh:

Substances:

Year:  2012        PMID: 23024374      PMCID: PMC3804750          DOI: 10.1096/fj.12-216473

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  47 in total

1.  CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.

Authors:  Xuerong Shi; Lin Leng; Tian Wang; Wenkui Wang; Xin Du; Ji Li; Courtney McDonald; Zun Chen; James W Murphy; Elias Lolis; Paul Noble; Warren Knudson; Richard Bucala
Journal:  Immunity       Date:  2006-10       Impact factor: 31.745

2.  SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress.

Authors:  Yonghua Yang; Wei Fu; Jiandong Chen; Nancy Olashaw; Xiaohong Zhang; Santo V Nicosia; Kapil Bhalla; Wenlong Bai
Journal:  Nat Cell Biol       Date:  2007-10-14       Impact factor: 28.824

3.  Resveratrol stimulates AMP kinase activity in neurons.

Authors:  Biplab Dasgupta; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

Review 4.  NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity.

Authors:  Tianle Yang; Anthony A Sauve
Journal:  AAPS J       Date:  2006-10-06       Impact factor: 4.009

5.  Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart.

Authors:  Edward J Miller; Ji Li; Lin Leng; Courtney McDonald; Toshiya Atsumi; Richard Bucala; Lawrence H Young
Journal:  Nature       Date:  2008-01-31       Impact factor: 49.962

6.  Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt.

Authors:  Marcella Fulco; Yana Cen; Po Zhao; Eric P Hoffman; Michael W McBurney; Anthony A Sauve; Vittorio Sartorelli
Journal:  Dev Cell       Date:  2008-05       Impact factor: 12.270

7.  SIRT1 activation confers neuroprotection in experimental optic neuritis.

Authors:  Kenneth S Shindler; Elvira Ventura; Tonia S Rex; Peter Elliott; Abdolmohamad Rostami
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

8.  Sirt1 regulates aging and resistance to oxidative stress in the heart.

Authors:  Ralph R Alcendor; Shumin Gao; Peiyong Zhai; Daniela Zablocki; Eric Holle; Xianzhong Yu; Bin Tian; Thomas Wagner; Stephen F Vatner; Junichi Sadoshima
Journal:  Circ Res       Date:  2007-04-19       Impact factor: 17.367

9.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.

Authors:  Jill C Milne; Philip D Lambert; Simon Schenk; David P Carney; Jesse J Smith; David J Gagne; Lei Jin; Olivier Boss; Robert B Perni; Chi B Vu; Jean E Bemis; Roger Xie; Jeremy S Disch; Pui Yee Ng; Joseph J Nunes; Amy V Lynch; Hongying Yang; Heidi Galonek; Kristine Israelian; Wendy Choy; Andre Iffland; Siva Lavu; Oliver Medvedik; David A Sinclair; Jerrold M Olefsky; Michael R Jirousek; Peter J Elliott; Christoph H Westphal
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

10.  Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation.

Authors:  Fang Wei; Hans R Schöler; Michael L Atchison
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

View more
  63 in total

1.  Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.

Authors:  Supriya R Kulkarni; Carol J Soroka; Lee R Hagey; James L Boyer
Journal:  Hepatology       Date:  2016-10-28       Impact factor: 17.425

2.  Cardiomyocyte-specific deletion of Sirt1 gene sensitizes myocardium to ischaemia and reperfusion injury.

Authors:  Lin Wang; Nanhu Quan; Wanqing Sun; Xu Chen; Courtney Cates; Thomas Rousselle; Xinchun Zhou; Xuezhong Zhao; Ji Li
Journal:  Cardiovasc Res       Date:  2018-05-01       Impact factor: 10.787

Review 3.  Sirtuins, aging, and cardiovascular risks.

Authors:  Gaia Favero; Lorenzo Franceschetti; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Age (Dordr)       Date:  2015-06-23

4.  Recovery of Indicators of Mitochondrial Biogenesis, Oxidative Stress, and Aging With (-)-Epicatechin in Senile Mice.

Authors:  Aldo Moreno-Ulloa; Leonardo Nogueira; Alonso Rodriguez; Jonathan Barboza; Michael C Hogan; Guillermo Ceballos; Francisco Villarreal; Israel Ramirez-Sanchez
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-20       Impact factor: 6.053

5.  Macromolecular crowding effect is critical for maintaining SIRT1's nuclear localization in cancer cells.

Authors:  Lidong Sun; Jia Fang
Journal:  Cell Cycle       Date:  2016-07-27       Impact factor: 4.534

6.  The SIRT1 activator SRT1720 extends lifespan and improves health of mice fed a standard diet.

Authors:  Sarah J Mitchell; Alejandro Martin-Montalvo; Evi M Mercken; Hector H Palacios; Theresa M Ward; Gelareh Abulwerdi; Robin K Minor; George P Vlasuk; James L Ellis; David A Sinclair; John Dawson; David B Allison; Yongqing Zhang; Kevin G Becker; Michel Bernier; Rafael de Cabo
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

7.  Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury.

Authors:  Jason A Funk; Rick G Schnellmann
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-03       Impact factor: 4.219

Review 8.  Small molecule SIRT1 activators for the treatment of aging and age-related diseases.

Authors:  Basil P Hubbard; David A Sinclair
Journal:  Trends Pharmacol Sci       Date:  2014-01-16       Impact factor: 14.819

Review 9.  Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Mahesh P Gupta
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

Review 10.  Sirt1: Role Under the Condition of Ischemia/Hypoxia.

Authors:  Xiaofei Meng; Jin Tan; Mengmeng Li; Shuling Song; Yuyang Miao; Qiang Zhang
Journal:  Cell Mol Neurobiol       Date:  2016-03-14       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.